Nerdy Girl Live Q&A on Mon, 11/21: Triple Threat Thanksgiving & Science Denial
Families/Kids Socializing Staying Safe Uncertainty and Misinformation
Chana Davis, PhD
Monday, 11/21/22, at 1:30 pm EST/10:30 am PST Join Those Nerdy Girls for timely advice on staying well during a “triple threat” holiday season and practical insights into science denial – why it happens and how to navigate tricky conversations. Hosted by Those Nerdy Girls with: Sara Gorman, PhD, MPH: Co-Founder of Critica, Author of Read more…
Does Evusheld protect against the new COVID-19 subvariants?
COVID Variants
Sarah Whitley Coles, MD
A: The new Omicron subvariants of the SARS-CoV-2 virus are likely to be resistant to the monoclonal antibodies in Evusheld. It is especially important that people get the bivalent COVID-19 booster vaccine to protect against infection. Evusheld is a combination of two monoclonal antibodies called tixagevimab and cilgavimab. It is used to PREVENT (not treat!) Read more…
Monday, 11/21/22, at 1:30 pm EST/10:30 am PST Join Those Nerdy Girls for timely advice on staying well during a “triple threat” holiday season and practical insights into science denial – why it happens and how to navigate tricky conversations. Hosted by Those Nerdy Girls with: Sara Gorman, PhD, MPH: Co-Founder of Critica, Author of Read more…
Does Evusheld protect against the new COVID-19 subvariants?
COVID VariantsSarah Whitley Coles, MD
A: The new Omicron subvariants of the SARS-CoV-2 virus are likely to be resistant to the monoclonal antibodies in Evusheld. It is especially important that people get the bivalent COVID-19 booster vaccine to protect against infection. Evusheld is a combination of two monoclonal antibodies called tixagevimab and cilgavimab. It is used to PREVENT (not treat!) Read more…
A: The new Omicron subvariants of the SARS-CoV-2 virus are likely to be resistant to the monoclonal antibodies in Evusheld. It is especially important that people get the bivalent COVID-19 booster vaccine to protect against infection. Evusheld is a combination of two monoclonal antibodies called tixagevimab and cilgavimab. It is used to PREVENT (not treat!) Read more…
